[go: up one dir, main page]

FR23C1050I2 - Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci - Google Patents

Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci

Info

Publication number
FR23C1050I2
FR23C1050I2 FR23C1050C FR23C1050C FR23C1050I2 FR 23C1050 I2 FR23C1050 I2 FR 23C1050I2 FR 23C1050 C FR23C1050 C FR 23C1050C FR 23C1050 C FR23C1050 C FR 23C1050C FR 23C1050 I2 FR23C1050 I2 FR 23C1050I2
Authority
FR
France
Prior art keywords
alkynylbenzene
disubstituted
salt
compound
disubstituted alkynylbenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR23C1050C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of FR23C1050I1 publication Critical patent/FR23C1050I1/fr
Application granted granted Critical
Publication of FR23C1050I2 publication Critical patent/FR23C1050I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
FR23C1050C 2012-01-19 2023-12-19 Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci Active FR23C1050I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012009467 2012-01-19
PCT/JP2013/050740 WO2013108809A1 (ja) 2012-01-19 2013-01-17 ３，５－二置換ベンゼンアルキニル化合物及びその塩

Publications (2)

Publication Number Publication Date
FR23C1050I1 FR23C1050I1 (fr) 2024-01-26
FR23C1050I2 true FR23C1050I2 (fr) 2024-12-13

Family

ID=48799233

Family Applications (1)

Application Number Title Priority Date Filing Date
FR23C1050C Active FR23C1050I2 (fr) 2012-01-19 2023-12-19 Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci

Country Status (23)

Country Link
US (1) US9108973B2 (ja)
EP (1) EP2657233B1 (ja)
JP (1) JP5355825B1 (ja)
KR (1) KR101623286B1 (ja)
CN (1) CN103958512B (ja)
AU (1) AU2013210403B2 (ja)
BR (1) BR112014017749B1 (ja)
CA (1) CA2854093C (ja)
DK (1) DK2657233T3 (ja)
ES (1) ES2516392T3 (ja)
FI (1) FIC20230038I1 (ja)
FR (1) FR23C1050I2 (ja)
HU (1) HUS2300043I1 (ja)
MX (1) MX351513B (ja)
MY (1) MY171055A (ja)
NL (1) NL301254I2 (ja)
NO (1) NO2023046I1 (ja)
PL (1) PL2657233T3 (ja)
PT (1) PT2657233E (ja)
RU (1) RU2576384C1 (ja)
SG (1) SG2014009286A (ja)
TW (1) TWI508964B (ja)
WO (1) WO2013108809A1 (ja)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
JP5873656B2 (ja) 2011-06-13 2016-03-01 株式会社Ihi 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤
ES2984771T3 (es) 2012-06-13 2024-10-31 Incyte Holdings Corp Compuestos tricíclicos sustituidos como inhibidores de FGFR
RU2019102203A (ru) 2012-07-11 2019-03-05 Блюпринт Медсинс Корпорейшн Ингибиторы рецептора фактора роста фибробластов
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
AR094812A1 (es) 2013-02-20 2015-08-26 Eisai R&D Man Co Ltd Derivado de piridina monocíclico como inhibidor del fgfr
EA035095B1 (ru) 2013-04-19 2020-04-27 Инсайт Холдингс Корпорейшн Бициклические гетероциклы в качестве ингибиторов fgfr
ES2819398T3 (es) * 2013-07-18 2021-04-15 Taiho Pharmaceutical Co Ltd Agente terapéutico para el cáncer resistente al inhibidor de FGFR
TWI574691B (zh) * 2013-07-18 2017-03-21 Taiho Pharmaceutical Co Ltd Anti - tumor agents for intermittent administration of FGFR inhibitors
CA2921208C (en) 2013-08-12 2018-02-20 Taiho Pharmaceutical Co., Ltd. Fused pyrimidine compound or salt thereof
PT3395814T (pt) 2013-10-25 2022-07-27 Blueprint Medicines Corp Inibidores do recetor do fator de crescimento de fibroblastos
JP6514645B2 (ja) 2013-12-27 2019-05-15 中外製薬株式会社 Ｆｇｆｒゲートキーパー変異遺伝子およびそれを標的とする医薬
WO2015108992A1 (en) 2014-01-15 2015-07-23 Blueprint Medicines Corporation Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
PT3103802T (pt) * 2014-06-24 2017-12-11 Taiho Pharmaceutical Co Ltd Novo composto de pirrolopirimidina ou seu sal, composição farmacêutica que o contém, especialmente agente para prevenção e/ou tratamento de tumores etc. com base no efeito inibidor de nae
US9951047B2 (en) 2014-08-18 2018-04-24 Eisai R&D Management Co., Ltd. Salt of monocyclic pyridine derivative and crystal thereof
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
CN105837575B (zh) * 2015-01-13 2019-01-15 四川大学 3-乙炔基吡唑并嘧啶衍生物及其制备方法和用途
TWI638817B (zh) * 2015-01-30 2018-10-21 大鵬藥品工業股份有限公司 免疫疾病之預防及／或治療劑
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EA038045B1 (ru) 2015-02-20 2021-06-28 Инсайт Корпорейшн Бициклические гетероциклы в качестве ингибиторов fgfr
EP3275442B1 (en) 2015-03-25 2021-07-28 National Cancer Center Therapeutic agent for bile duct cancer
CN111393446B (zh) * 2015-03-31 2022-12-20 大鹏药品工业株式会社 3,5-二取代的苯炔基化合物晶体
US10479780B2 (en) 2015-06-17 2019-11-19 Chugai Seiyaku Kabushiki Kaisha Aminopyrazole derivatives
EP3345907B1 (en) * 2015-09-01 2020-04-22 Taiho Pharmaceutical Co., Ltd. Pyrazolo[3,4-d]pyrimidine compounds or salts thereof
WO2017104739A1 (ja) 2015-12-17 2017-06-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 乳がん治療剤
TWI623316B (zh) * 2015-12-22 2018-05-11 Taiho Pharmaceutical Co Ltd Antitumor effect enhancer derived from pyrrolopyrimidine compound
HRP20200352T1 (hr) * 2016-02-23 2020-06-12 Taiho Pharmaceutical Co., Ltd. Novi kondenzirani pirimidinski spoj ili njegova sol
US11883404B2 (en) * 2016-03-04 2024-01-30 Taiho Pharmaceuticals Co., Ltd. Preparation and composition for treatment of malignant tumors
KR20220110859A (ko) * 2016-03-04 2022-08-09 다이호야쿠힌고교 가부시키가이샤 악성 종양 치료용 제제 및 조성물
CN107344940B (zh) * 2016-05-06 2020-04-21 广东东阳光药业有限公司 Btk抑制剂及其用途
CN107698593A (zh) * 2016-08-09 2018-02-16 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
MA47696A (fr) * 2017-02-28 2020-01-08 Taiho Pharmaceutical Co Ltd Activateur d'effet antitumoral utilisant un composé pyrazolo[3,4-d]pyrimidine
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
JOP20180094A1 (ar) 2017-10-18 2019-04-18 Hk Inno N Corp مركب حلقي غير متجانس كمثبط بروتين كيناز
CN109776544B (zh) * 2017-11-15 2022-02-01 上海医药工业研究院 吡唑并[3,4-d]嘧啶类化合物及其制备方法和用途
RU2759746C1 (ru) 2018-03-19 2021-11-17 Тайхо Фармасьютикал Ко., Лтд. Фармацевтическая композиция, включающая алкилсульфат натрия
BR112020017922A2 (pt) 2018-03-28 2020-12-22 Eisai R&D Management Co., Ltd. Agente terapêutico para carcinoma hepatocelular
US11174257B2 (en) 2018-05-04 2021-11-16 Incyte Corporation Salts of an FGFR inhibitor
RS66310B1 (sr) 2018-05-04 2025-01-31 Incyte Corp Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu
JP7162372B2 (ja) 2018-07-02 2022-10-28 深▲チェン▼市塔吉瑞生物医薬有限公司 キナーゼ活性を阻害するためのアルキニル（ヘテロ）芳香族化合物
WO2020096050A1 (ja) 2018-11-09 2020-05-14 大鵬薬品工業株式会社 ジメトキシベンゼン化合物の類縁物質、該化合物の分析方法及び標準品
WO2020095452A1 (ja) * 2018-11-09 2020-05-14 大鵬薬品工業株式会社 ジメトキシベンゼン化合物の製造方法
KR102195348B1 (ko) 2018-11-15 2020-12-24 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
EP3888643A4 (en) * 2018-11-26 2022-08-24 Taiho Pharmaceutical Co., Ltd. Therapeutic and prophylactic method for tumor treatable with endocrine therapy by combined use of fibroblast growth factor receptor inhibitor with endocrine therapy
WO2020170355A1 (ja) * 2019-02-20 2020-08-27 大鵬薬品工業株式会社 Ｆｇｆｒ１変異腫瘍の治療方法
WO2020175704A1 (ja) * 2019-02-28 2020-09-03 大鵬薬品工業株式会社 ３，５－二置換ベンゼンアルキニル化合物と免疫チェックポイント阻害薬とを用いた癌治療法
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
KR20210142154A (ko) 2019-03-21 2021-11-24 옹쎄오 암 치료를 위한 키나제 억제제와 조합된 dbait 분자
MX2021013146A (es) * 2019-05-13 2022-01-24 Relay Therapeutics Inc Inhibidores de receptores del factor de crecimiento de fibroblastos (fgfr) y metodos de uso de los mismos.
CA3139161A1 (en) * 2019-05-17 2020-11-26 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases
EP3988175A4 (en) 2019-06-21 2023-06-28 Taiho Pharmaceutical Co., Ltd. Method for treating malignant tumor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
PH12022550892A1 (en) 2019-10-14 2023-05-03 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN114761006A (zh) 2019-11-08 2022-07-15 Inserm(法国国家健康医学研究院) 对激酶抑制剂产生耐药性的癌症的治疗方法
CN114641293B (zh) * 2019-11-08 2024-05-31 石药集团中奇制药技术（石家庄）有限公司 一种fgfr抑制剂的用途
AU2020395185A1 (en) 2019-12-04 2022-06-02 Incyte Corporation Derivatives of an FGFR inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
EP4098263A4 (en) 2020-01-31 2024-03-20 Kyoto University TREATMENT FOR CHONDRODYSTROPHY
CN116057045A (zh) 2020-06-05 2023-05-02 金耐特生物制药公司 成纤维细胞生长因子受体激酶抑制剂
EP4183395A4 (en) * 2020-07-15 2024-07-24 Taiho Pharmaceutical Co., Ltd. PYRIMIDINE COMPOUND-CONTAINING COMBINATION FOR USE IN TUMOR TREATMENT
TWI797711B (zh) * 2020-08-13 2023-04-01 大陸商上海和譽生物醫藥科技有限公司 一種fgfr及其突變抑制劑，其製備方法和應用
CN115867547B (zh) * 2020-08-27 2024-12-20 上海和誉生物医药科技有限公司 一种1h-吡唑-4-酰胺衍生物，其制备方法和应用
TW202233625A (zh) 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法
CA3199714A1 (en) * 2020-11-20 2022-05-27 Isao Miyazaki Brain-migrating tumor therapeutic agent containing fused pyrimidine compound as active ingredient
CN114805359B (zh) * 2021-01-28 2023-10-27 药雅科技(上海)有限公司 炔代杂环化合物fgfr抑制剂的制备方法和用途
CN115028634B (zh) * 2021-03-08 2023-11-28 药雅科技(上海)有限公司 一种炔代吡嗪并杂环类fgfr抑制剂及其制备方法和用途
KR20230170668A (ko) * 2021-03-08 2023-12-19 다이호야쿠힌고교 가부시키가이샤 Fgfr2 및 암 유발 유전자의 동시발생 유전자 변형이 있는 환자의 암 치료
JP2024513575A (ja) 2021-04-12 2024-03-26 インサイト・コーポレイション Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
WO2022261160A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
TW202313610A (zh) 2021-06-09 2023-04-01 美商英塞特公司 作為ｆｇｆｒ抑制劑之三環雜環
CN115785103A (zh) * 2022-12-28 2023-03-14 北京康立生医药技术开发有限公司 一种治疗胆管癌药物福巴替尼的合成方法
WO2025178019A1 (ja) * 2024-02-19 2025-08-28 国立大学法人大阪大学 繊毛病治療用医薬組成物
CN119080780A (zh) * 2024-08-29 2024-12-06 武汉九州钰民医药科技有限公司 一种富替巴替尼的制备方法
CN120172981B (zh) * 2025-05-20 2025-07-25 南京工业大学 一类以fgfr2为靶点的小分子降解剂及其药物组合物和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007087395A2 (en) * 2006-01-25 2007-08-02 Osi Pharmaceuticals, Inc. UNSATURATED mTOR INHIBITORS
EA017865B1 (ru) * 2007-03-28 2013-03-29 Фармасайкликс, Инк. Ингибиторы тирозинкиназы брутона
GB0819105D0 (en) * 2008-10-17 2008-11-26 Chroma Therapeutics Ltd Pyrrolo-pyrimidine compounds
KR101483215B1 (ko) * 2010-01-29 2015-01-16 한미약품 주식회사 단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
EA201890869A3 (ru) * 2010-06-03 2019-03-29 Фармасайкликс, Инк. Применение ингибиторов тирозинкиназы брутона (btk)

Also Published As

Publication number Publication date
KR101623286B1 (ko) 2016-05-20
SG2014009286A (en) 2014-04-28
MX351513B (es) 2017-10-17
ES2516392T3 (es) 2014-10-30
EP2657233B1 (en) 2014-08-27
AU2013210403B2 (en) 2016-01-14
BR112014017749B1 (pt) 2021-08-03
AU2013210403A1 (en) 2014-06-26
FIC20230038I1 (fi) 2023-12-18
CN103958512A (zh) 2014-07-30
US9108973B2 (en) 2015-08-18
CA2854093C (en) 2016-07-05
WO2013108809A1 (ja) 2013-07-25
BR112014017749A8 (pt) 2017-07-11
DK2657233T3 (da) 2014-09-22
EP2657233A1 (en) 2013-10-30
HK1198164A1 (zh) 2015-03-13
KR20140080551A (ko) 2014-06-30
PL2657233T3 (pl) 2015-01-30
FR23C1050I1 (fr) 2024-01-26
MX2014008605A (es) 2014-08-27
NL301254I1 (ja) 2023-12-20
RU2576384C1 (ru) 2016-03-10
JPWO2013108809A1 (ja) 2015-05-11
NL301254I2 (nl) 2024-01-10
NO2023046I1 (no) 2023-12-20
PT2657233E (pt) 2014-10-24
JP5355825B1 (ja) 2013-11-27
US20140343035A1 (en) 2014-11-20
EP2657233A4 (en) 2013-12-04
TW201335156A (zh) 2013-09-01
CN103958512B (zh) 2016-01-20
MY171055A (en) 2019-09-23
BR112014017749A2 (pt) 2017-06-20
HUS2300043I1 (hu) 2024-01-28
CA2854093A1 (en) 2013-07-25
TWI508964B (zh) 2015-11-21

Similar Documents

Publication Publication Date Title
FR23C1050I2 (fr) Compose d'alkynylbenzene 3,5-disubstitue et un sel de celui-ci
KR102048688B9 (ko) 질소 함유 헤테로 방향족환 화합물
HUE036582T2 (hu) Nitrogéntartalmú heterociklusos vegyület vagy annak sója
DK3686194T3 (da) 2-(2,4,5-substitueret-anilino)pyrimidinforbindelser
BR302012005333S1 (pt) "configuração aplicada em tampa".
DK2540728T3 (da) Heterocyklisk forbindelse
EP2889291A4 (en) HETEROCYCLIC CONNECTION
LT3246016T (lt) Sausų miltelių vaisto forma, apimanti fosfodiesterazės inhibitorių
EP2933247A4 (en) HETEROCYCLIC CONNECTION
PL2703054T3 (pl) Przyłączalny klocek
EP2873669A4 (en) HETEROCYCLIC CONNECTION
EP2857400A4 (en) HETEROCYCLIC CONNECTION
EP2818473A4 (en) HETEROCYCLIC CONNECTION
EP2738163A4 (en) AMIDINE COMPOUND OR SALT THEREOF
EP2821406A4 (en) NOVEL PIPERIDINE COMPOUNDS OR SALT THEREOF
CL2014003459A1 (es) Compuestos fungicidas heterocíclicos.
EP2727920A4 (en) 1,5-naphthyridine derivative or salt thereof
EP2927229A4 (en) Heterocyclic compound
BR112013010643A2 (pt) compostos heterocíclicos
CL2014002034A1 (es) Compuestos derivados de isoxazol-fenil-azetidina fenil sustituidos; y compuestos intermediarios.
EP2662357A4 (en) NEW BICYCLIC COMPOUND OR SALT THEREOF
EP2609093A4 (en) SALT CONNECTION
EP2930176A4 (en) Hydantoin derivative
BR112013031570A2 (pt) inalador de pó seco.
CL2015001192A1 (es) Composición herbicida